✦ LIBER ✦

A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT)

✍ Scribed by Turpie, Alexander G. G.; Bauer, Kenneth A.; Davidson, Bruce L.; Fisher, William D.; Gent, Michael; Huo, Michael H.; Sinha, Uma; Gretler, Daniel D.

Book ID: 120259803
Publisher: Schattauer
Year: 2009
Tongue: English
Weight: 456 KB
Volume: 101
Category: Article
ISSN: 0340-6245
DOI: 10.1160/TH08-07-0460

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rivaroxaban-an oral, direct Factor Xa in

Rivaroxaban-an oral, direct Factor Xa inhibitor-for the prevention of venous thromboembolism after total knee replacement: Results of a randomized multi-center trial

✍ Jay R. Lieberman; Nadia Rosencher; Frank Misselwitz 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 20 KB

BAY 59-7939: an oral, direct Factor Xa i

BAY 59-7939: an oral, direct Factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study

✍ A. G. G. TURPIE; W. D. FISHER; K. A. BAUER; L. M. KWONG; M. W. IRWIN; P. KÄLEBO; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB

A phase II study of the oral factor Xa i

A phase II study of the oral factor Xa inhibitor LY517717 for the prevention of venous thromboembolism after hip or knee replacement

✍ G. AGNELLI; S. HAAS; J. S. GINSBERG; K. A. KRUEGER; A. DMITRIENKO; J. T. BRANDT 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 533 KB

A dose-ranging study evaluating the oral

A dose-ranging study evaluating the oral factor Xa inhibitor edoxaban for the prevention of venous thromboembolism in patients undergoing total knee arthroplasty

✍ T. FUJI; S. FUJITA; S. TACHIBANA; Y. KAWAI 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 362 KB

A new oral direct thrombin inhibitor, da

A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial

✍ B. I. ERIKSSON; O. E. DAHL; H. R. BÜLLER; R. HETTIARACHCHI; N. ROSENCHER; M-L. B 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

Prevention of venous thromboembolism wit

Prevention of venous thromboembolism with an oral factor Xa inhibitor, YM150, after total hip arthroplasty. A dose finding study (ONYX-2)

✍ B. I. ERIKSSON; A. G. G. TURPIE; M. R. LASSEN; M. H. PRINS; G. AGNELLI; P. KÄLEB 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB